Business Context and Reporting Period
Company: NeuroOne Medical Technologies Corp (NMTC)
Filing Type: Form 8-K (Current Report)
Date of Report: February 3, 2025
Reporting Period: Event-based report regarding Nasdaq listing compliance status.
Key Financial Metrics
This filing is a current report regarding corporate governance and listing status. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data.
Material Changes
- Nasdaq Compliance: The Company received confirmation from the Nasdaq Listing Qualifications Department that it has regained compliance with the bid price requirement under Nasdaq Listing Rule 5550(a)(2).
- Listing Status: The previously scheduled hearing before the hearings panel has been cancelled. The Company's common stock will remain listed on The Nasdaq Stock Market LLC.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the resolution of the listing deficiency. A press release dated February 4, 2025, was issued to announce this compliance (attached as Exhibit 99.1).
Risks and Contingencies: The immediate risk of delisting due to the bid price requirement has been mitigated as of the report date. No other risks or unusual items are disclosed in this specific filing.
Investor Verification Checklist
- Verify the current trading price of NMTC to ensure continued compliance with Nasdaq bid price rules.
- Review the attached press release (Exhibit 99.1) for any additional context on the compliance timeline.
- Monitor future filings for any recurrence of listing deficiencies or new material events.